Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer

The treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced non-small-cell lung cancer (NSCLC) is challenging because there is no randomized controlled trial has been reported. The value of neoadjuvant and adjuvant targeted therapy remains unclear. Herein, we show that systemic treat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Xie, Xiao-Hong, Zhan, Ze-Jiang, Qin, Yin-Yin, Jiang, Ju-Hong, Yin, Wei-Qiang, Zheng, Rong-Hui, Li, Shi-Yue, Zhou, Cheng-Zhi
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2021
Fag:
Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010235/
https://ncbi.nlm.nih.gov/pubmed/33816312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.655856
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker